Page last updated: 2024-09-04

levofloxacin and Urinary Tract Infections

levofloxacin has been researched along with Urinary Tract Infections in 150 studies

Research

Studies (150)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (5.33)	18.2507
2000's	55 (36.67)	29.6817
2010's	64 (42.67)	24.3611
2020's	23 (15.33)	2.80

Authors

Authors	Studies
Naber, KG; Redman, R; Wagenlehner, C; Wagenlehner, FM; Weidner, W	1
Hedrich, D; Kaniga, K; Kotey, P; Llorens, L; Naber, KG; Redman, R	1
Blango, MG; Mulvey, MA	1
Cheng, CY; Chung, WH; Tsai, YW; Wang, CW	1
Li, Y; Xiang, Y; Xue, Z; Yang, Q	1
Fang, SB; Fujisawa, M; Mukai, S; Nomi, M; Onishi, R; Sengoku, A; Shigemura, K; Yanagiuchi, A; Yang, YM	1
Aden, JK; Benavides, TM; Giancola, SE	1
Bezruk, VV; Bulyk, TS; Buriak, OH; Godovanets, OS; Honcharuk, LM; Hresko, MD; Hresko, MM; Makarova, OV; Pervozvanska, OI; Rynzhuk, LV; Sheremet, MI; Shkrobanets, ID; Velia, MI; Voytkevich, NI; Yurkiv, OI; Yurniuk, SV	1
Al Atbee, MYN; Jalil, MB	1
Crawford, SB; Davis, WH; Geno, KA; Magee, MR; Monks, SM	1
Baba, T; Boucher, HW; Chambers, HF; Collyar, D; Dai, W; Doernberg, SB; Evans, SR; Fowler, VG; Gelone, SP; Hamasaki, T; Hill, C; Holland, TL; Howard-Anderson, J; Kinamon, T; Mariano, D; Nambiar, S; Rubin, D	1
Bykov, K; Fischer, MA; Gagne, JJ; Kattinakere-Sreedhara, S; Wang, J	1
Holmes, M; Wildermuth, A	1
Abbas Tikki, K; Hayder Hasan, T; Sabah Bustani, G; Sadeq Al-Ethari, A	1
Guo, S; Li, X; Li, Y; Shao, J; Tian, M; Tong, H; Wei, M; Xu, B; Yan, B	1
Afriansyah, A; Leonardo, K; Manurung, MA; Purwanto, HPA; Rahardjo, HE; Rizaly, AA; Soedarman, S; Wicaksono, I; Widia, F	1
Ge, H; Li, N; Yan, L; Zhang, Y	1
Mo, L; Peng, M; Qian, J; Wang, J	1
Chunqing, L; Li, X; Rui, W; Ruijuan, Z; Yingjie, W	1
Chacko, S; Maheshwari, TK; Murdeshwar, S; Sheikh, RY	1
Akcali, A; Alkan, B; Bozkurt-Guzel, C; Demir, ES; Eltimur, T; Oyardi, O; Savage, PB	1
Link, I; Loose, M; Naber, KG; Wagenlehner, FME	1
Bientinesi, R; Murri, R; Sacco, E	1
Chihara, Y; Egawa, S; Fujimoto, K; Fujimoto, Y; Goto, H; Hamasuna, R; Hanaki, H; Hayami, H; Hiroshi, M; Hiyama, Y; Homma, Y; Inatomi, H; Ishihara, S; Ishikawa, K; Ito, N; Ito, T; Kamei, J; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Koda, S; Komeda, H; Masue, T; Masumori, N; Matsubara, A; Matsukawa, M; Matsumoto, K; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Miyazaki, J; Mori, K; Nishimura, K; Nishiyama, H; Oka, Y; Okumura, K; Sato, J; Shigeta, M; Shoji, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Tateda, K; Togo, Y; Torimoto, K; Tsugawa, M; Uehara, S; Wada, K; Watanabe, S; Yamada, D; Yamada, H; Yamamoto, S; Yamashita, M; Yasuda, M; Yasufuku, T	1
Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y	1
Marra, A; Pagano, P; Pillar, C; Shinabarger, D	1
Abolghasemi, S; Elyasi, F; Tehrani, S	1
Conigliaro, A; Grodin, L; Lee, SY; Rose, M; Sinert, R	1
Huntington, JA; Long, J; Popejoy, MW	1
Monogue, ML; Nicolau, DP	1
Judd, WR; Ratliff, PD; Wang, SS	1
Doi, SAR; Harris, PN; Naber, K; Roberts, MJ; Scott, S; Wagenlehner, FME	1
Armstrong, ES; Cebrik, D; Connolly, LE; Miller, LG; Riddle, V	1
Hendrich, AB; Kicia, M; Kopacz, Ż; Kváč, M; Sak, B; Sędzimirska, M; Wesołowska, M	1
Ben Salem, C; Brahim, A; Fathallah, N; Ouni, B; Slim, R	1
Adu, LB; Afriyie, DK; Amponsah, SK; Dzradosi, M; Manu-Ofei, F; Ohene-Manu, P	1
Jiang, JH; Ma, Q; Su, R; Wang, KY; Yan, ZJ; Zhang, D	1
Arnold, JR; Dierkhising, RA; Narayanan, PP; Sampathkumar, P; Thurber, KM	1
Hori, S; Iida, K; Morizawa, Y; Nakagawa, Y; Naoi, M; Omori, C; Otsuka, K; Tani, M	1
Deng, YY; Gao, WX; Gao, Z; Lyu, J; Shen, JW; Wang, LX; Wang, ZF; Xiang, ST; Xie, YM; Yi, DH; Zeng, WT; Zhang, CH	1
Carbonell, J; Castillo, D; Cataño, JG; García-Perdomo, HA; López, H; Serón, P	1
Debrix, I; Hertig, A; Rafat, C	1
Kurtinecz, M; Li, G; Mitrani-Gold, FS; Mundy, LM; Singh, KP; Tomayko, JF; Wetherington, J	1
Chang, SJ; Hsieh, CH; Lin, CD; Yang, SS	1
Arakawa, S; Fujisawa, M; Miyake, H; Shigemura, K; Tanaka, K	1
Chang, HC; Chiang, BJ; Chiang, IN; Chung, SD; Huang, CY; Liu, SP; Pu, YS; Wang, SM; Yu, HJ	1
Fleming, VH; Southwood, R; White, BP	1
Grossman, TH; Kerstein, KO; O'Brien, W; Sutcliffe, JA	1
Chang, FY; Chiu, CH; Lin, DY; Lin, HA; Lin, HC; Lin, JC; Wang, JX; Yang, YS; Yeh, KM	1
Darouiche, RO; Steenbergen, J; Umeh, O; Wagenlehner, FM; Yuan, G	1
Chan, JF; Yuen, KY	1
Edwards, JK	1
Barvaliya, M; Jha, P; Naik, V; Tripathi, C; Vachhani, AV	1
Biscaro, V; Caruso, A; De Francesco, MA; Gargiulo, F; Piccinelli, G	1
Chan, S; Coulter, MM; Di Pentima, MC; Hossain, J; Rosé, L	1
Al-Salamah, T; Hayes, BD; Heil, EL; Hines, MC; Johnson, JK; Mallemat, H; Winters, ME; Witting, MD	1
Berghofen, A; Krämer, BK; Krüger, B; Mircheva, M; Popa, C	1
Boyles, T	1
Kielstein, JT; Schmidt, JJ	1
Darouiche, RO; Umeh, O; Wagenlehner, FM	1
Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S	1
Geerlings, SE; Holleman, F; Schneeberger, C	1
Chang, SJ; Hsieh, CH; Yang, SS	1
Akamatsu, S; Iguchi, R; Ito, M; Ito, N; Kamiyama, Y; Kanamaru, S; Miyazaki, Y; Ogura, K; Sano, T; Sengiku, A; Takahashi, A; Takenawa, J	1
Bliss, C; Cloutier, DJ; Goldstein, EJ; Huntington, JA; Sakoulas, G; Steenbergen, JN; Umeh, O	1
Afriansyah, A; Akbar, MI; Parikesit, D; Rahardjo, HE; Tirtayasa, PM	1
Li, Y; Lyu, Y; Xue, F; Zheng, B; Zhu, SN	1
Bliss, CA; Cloutier, D; Hershberger, E; Huntington, JA; Kaye, KS; Miller, B; Paterson, DL; Popejoy, MW; Steenbergen, JN; Umeh, O	1
Armstrong, ES; Bliss, CA; Cloutier, DJ; Mikulca, JA; Steenbergen, JN	1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF	1
Mospan, GA; Wargo, KA	1
Cao, B; Cen, J; Chen, N; Cheng, H; Hu, Y; Li, X; Li, YF; Liu, YH; Ni, ZH; Niu, JY; Qiu, XH; Ren, AM; Ren, H; Tu, XW; Xing, CY; Xu, J; Xu, XD; Zhou, R	1
Dalhoff, A; Schubert, S; Vente, A	1
Al-Hasan, MN; Albrecht, H; Bookstaver, PB; Justo, JA; Kohn, J; Shah, A	1
Burman, WJ; Everhart, RM; Johnson, L; MacKenzie, TD; Mehler, PS; Price, CS; Rome, M; Rozwadowski, J; Sabel, A	1
Cao, DY; Wang, JH; Zhang, Y; Zhu, L	1
Chen, YH; Eng, HL; Huang, CK; Lai, CH; Lin, HF; Lin, HH; Lin, JN	1
Chen, BY; Ding, GH; Duan, J; Gu, JM; Guo, DY; Hao, QL; Huang, HH; Huang, JA; Li, HY; Li, QH; Liu, A; Lü, XJ; Ma, H; Ren, ZY; Shen, HH; Shi, MH; Si, B; Sun, SH; Sun, TY; Wu, GM; Xia, QM; Xiao, W; Xiao, ZK; Xiu, QY; Yang, HF; Yang, HP; Yao, WZ; Ying, KJ; Yu, YS; Yue, HM; Zhang, W; Zhang, YY; Zheng, HG	1
Aihara, M; Akiyama, T; Akizawa, K; Aoki, Y; Asano, Y; Baba, H; fujimoto, Y; Fujita, J; Fujita, S; Fujiwara, H; Genma, H; Gonda, H; Haruki, K; Hashikita, G; Hayashi, M; Heijyou, H; Hida, Y; Hiramatsu, K; Horiuchi, H; Ichiyama, S; Idomuki, M; Ieiri, T; Ikeda, N; Inuzuka, K; Iriyama, J; Ishii, Y; Ito, T; Iwata, M; Kaku, M; Kamioka, M; Kanda, M; Kang, D; Kanno, H; Katayama, Y; Kato, J; Kawahara, K; Kawamura, C; Kawano, S; Kawashima, C; Kinoshita, S; Kobayashi, Y; Kohno, S; Koike, K; Kon, S; Kondou, S; Kono, H; Kumasaka, K; Kusaba, K; Kusakabe, T; Kusano, N; Kuwabara, M; Maekawa, M; Maesaki, S; Masaki, H; Mashiba, K; Matsuda, J; Matsuda, K; Matsuo, S; Miki, M; Misawa, S; Miyajima, E; Miyanohara, H; Moro, K; Murakami, M; Murase, M; Murata, M; Nagai, A; Nakagawa, T; Nakamura, K; Nakashima, Y; Nakasone, I; Nakatani, K; Nakaya, H; Negayama, K; Ohno, A; Oka, M; Okabe, H; Okada, M; Okamoto, H; Okamoto, Y; Okayama, A; Okazaki, T; Okubo, S; Ono, J; Ota, H; Ozaki, Y; Saikawa, T; Saito, T; Sano, R; Sekine, I; Shigeta, M; Shimizu, C; Shiotani, J; Soma, M; Sugita, A; Sugiura, T; Sumitomo, M; Suwabe, A; Takubo, T; Taniguchi, N; Tashiro, H; Tateda, K; Tazawa, Y; Tominaga, M; Toyoshima, S; Uchida, T; Yamaguchi, I; Yamaguchi, K; Yamahata, K; Yamamoto, G; Yamamoto, Y; Yamane, N; Yamashita, M; Yamazaki, K; Yanagihara, K; Yasujima, M; Yoneyama, A; Yoshida, H; Yoshimura, H; Yuzuki, Y	1
Arakawa, S; Deguchi, T; Matsumoto, T; Monden, K; Nakane, K; Shimizu, T; Yasuda, M	1
De Vecchi, E; Drago, L; Mattina, R; Nicola, L	1
Mirone, V	1
Bush, LM; Kaye, D	1
Arakawa, S; Fujisawa, M; Kawabata, M; Kinoshita, S; Nakano, Y; Nishimura, K; Shigemura, K; Shirakawa, T; Tanaka, K; Yasufuku, T	1
Khawcharoenporn, T; Singh, K; Vasoo, S; Ward, E	1
Damiao, R; Davies, T; Kaniga, K; Kotey, P; Naber, KG; Redman, R	1
Deguchi, T; Matsumoto, T; Seike, K; Yasuda, M	1
Arakawa, S; Fujisawa, M; Kawabata, M; Matsumoto, M; Nakano, Y; Shigemura, K; Shirakawa, T; Tanaka, K; Yasufuku, T	1
Arakawa, S; Fujisawa, M; Matsumoto, M; Nakano, Y; Shigemura, K; Tanaka, K; Yamamichi, F	1
Malithong, A; Phiboonbanakit, D; Santiwatanakul, S; Srisangchan, P; Srisurat, N; Susaengrat, W; Tantisiriwat, W; Thamlikitkul, V; Thunyaharn, S; Tiengrim, S	1
Agresti, E; Corbisiero, MC; Esposito, S; Fiore, A; Freda, F; Petronella, P; Scorzelli, M	1
Abe, Y; Ikegami, Y; Nemoto, C; Shimada, J; Tase, C; Tsukada, Y	1
Chen, Y; Huang, W; Li, Q; Lu, G; Lv, X; Sun, Y; Wu, G; Wu, X; Wu, Y; Yang, H; Zhang, G	1
Chen, PL; Hung, YP; Ko, WC; Wu, YH	1
Chaki, Y; Imai, T; Kusano, E; Takeda, S	1
Schaeffer, AJ	1
Ali-Khan, MM; Canby-Hagino, E; Foley, JP; Griffith, BC; Morey, AF; Rozanski, TA	1
Fujimoto, N; Iihara, K; Inatomi, H; Kobayashi, T; Matsumoto, T; Muratani, T; Nishimura, T; Takahashi, K; Yamada, Y	1
Bastacky, S; Johnson, JP; Ramalakshmi, S	1
Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yoshimori, K	1
Esposito, S; Ianniello, F; Leone, S; Noviello, S	2
Marchetti, F; Trinchieri, A	1
Chan, KW; Kung, WH; Li, R; Tam, VK	1
Graff, HJ; Knopf, HJ; Schulze, H	1
Naber, KG	1
Akins, RL; Davis, WR; Gopalachar, A; Siddiqui, AA	1
Padeĭskaia, EN	1
Dib, C; Durand, C; Moniot-Ville, N; Weber, P	1
Naber, KG; Schinzel, S; Wagenlehner, C; Wagenlehner, FM	1
Bovianska, N; Chukov, I; Markova, B; Panchev, P; Proevska, Iu; Slavov, Ch	1
Ivanov, DV; Sidorenko, SV	1
Blondeau, JM; Hansen, GT	1
Byrns, K; Goldner, B; Makaryus, AN; Makaryus, MN; Natarajan, U; Singer, C	1
Ascione, T; Esposito, S; Gaeta, GB; Ianniello, F; Leone, S; Noviello, S	1
Akcay, A; Aydogan, T; Bozalan, R; Isik, A; Kanbay, M; Kaya, A; Uz, B	1
Ashaber, D; Benkõ, R; Kovacs, B; Nagy, E; Tenke, P	1
Gorman, PH; Johnson, JA; Roghmann, MC; Wallin, MT	1
Elias, N; Kovalev, J; Naschitz, JE; Zaigraykin, N	1
Drago, L; Esposito, S; Leone, S; Marchetti, F; Marvaso, A; Noviello, S	1
Concia, E; Marchetti, F	1
Gualco, L; Marchese, A; Schito, AM; Schito, GC	1
Budanov, SV; Ivanov, DV	1
Konishi, I; Kumata, M; Yamamoto, A	1
Erkin, G; Isik, SR; Kalyoncu, AF; Karakaya, G	1
Arakawa, S; Fujisawa, M; Kamidono, S; Matsui, T; Miura, T; Nakano, Y; Shigemura, K; Takenaka, A; Tanaka, K	1
Fisher, A; Kahn, JB; Kaul, S; Khashab, M; Peterson, J	1
Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Peterson, J	1
Miyagi, T; Nakashima, T; Shigehara, K; Shimamura, M	1
Berman, AL; Chow, AT; Corrado, M; Dornseif, B; Drusano, GL; Fowler, CL; Natarajan, J; Preston, SL; Reichl, V	1
Chuck, SK; Jung, R; Martin, SJ; Messick, CR; Meyer, JM; Pendland, SL	1
Callery-D'Amico, S; Cox, CE; Fowler, CL; Kim, SS; King, W; Klimberg, IW	1
Lamb, HM; Langtry, HD	1
Redondo Sánchez, J	1
Funato, T; Hongo, T; Igari, J; Iinuma, Y; Ishigo, S; Ishii, K; Ishii, M; Itoh, C; Iwata, M; Kaimori, M; Kaku, M; Kamihira, S; Kanda, M; Kashitani, F; Katoh, J; Kawahara, S; Kawamura, C; Kudoh, M; Kuwabara, M; Matsudou, Y; Matsushima, T; Miyashita, N; Miyazaki, S; Miyazaki, Y; Murakami, N; Nakagawa, K; Nakasone, I; Negayama, K; Niki, Y; Nisawataira, T; Oguri, T; Okada, J; Ono, J; Saito, Y; Sato, N; Taira, M; Takada, T; Takii, M; Tamaki, I; Tashiro, H; Tazawa, Y; Toyoshima, S; Tsujio, Y; Uehara, N; Ueno, K; Watanabe, N; Yamaguchi, K; Yamanaka, K; Yasujima, M; Yoshida, T	1
Scheen, AJ	1
Garvin, CG; Jung, R; Martin, SJ	1
Mousavi, MS; O'Donoghue, S; Paltoo, B	1
De Vecchi, E; Drago, L; Gismondo, MR; Mombelli, B; Nicola, L; Valli, M	1
Gupta, K; Hooton, TM; Roberts, PL; Stamm, WE	1
Peng, MY	1
Armenian, B; Hadengue, A; Marinescu, O; Rubbia-Brandt, L; Spahr, L	1
Budanov, SV; Smirnova, LB; Vasil'ev, AN	1
Beach, ML; Jones, RN; Pfaller, MA	1
Trinchiere, A	1
Arai, G; Hayashi, T; Hyochi, N; Kageyama, Y; Kawakami, S; Kihara, K; Kobayashi, T; Masuda, H; Okuno, T; Saito, K; Sakai, Y; Suzuki, M	1
Bahar, IH; Baskin, H; Doğan, Y; Yuluğ, N	1
Lizzano, R; Mangiarotti, B; Trinchieri, A	1
Kumazawa, J; Matsumoto, T	1
Horiba, M; Suzuki, K	1

Reviews

21 review(s) available for levofloxacin and Urinary Tract Infections

Article	Year
A systematic review and meta-analysis of levofloxacin and ciprofloxacin in the treatment of urinary tract infection. Annals of palliative medicine, 2021, Volume: 10, Issue:9 Topics: Ciprofloxacin; Humans; Levofloxacin; Urinary Tract Infections	2021
Epidemiology of pathogens and antimicrobial resistance of nosocomial urinary tract infections in patients with spinal cord injuries in China: A systematic review and meta-analysis. The journal of spinal cord medicine, 2023, Volume: 46, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Humans; Levofloxacin; Spinal Cord Injuries; Urinary Tract Infections	2023
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:6 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Humans; Infection Control; Levofloxacin; Pyelonephritis; Sepsis; Urinary Tract Infections	2020
Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. World journal of urology, 2018, Volume: 36, Issue:3 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Biopsy, Large-Core Needle; Ciprofloxacin; Fluoroquinolones; Fosfomycin; Humans; Image-Guided Biopsy; Levofloxacin; Male; Middle Aged; Prostate; Sepsis; Ultrasonography; Urinary Tract Infections	2018
Levofloxacin for the treatment of pyelonephritis. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:9 Topics: Administration, Oral; Ambulatory Care; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Levofloxacin; Practice Guidelines as Topic; Pyelonephritis; Urinary Tract Infections	2013
Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Databases, Bibliographic; Doripenem; Drug Combinations; Female; Humans; Imipenem; Levofloxacin; Male; Research Design; Treatment Outcome; Urinary Tract Infections	2013
Febrile urinary tract infections: pyelonephritis and urosepsis. Current opinion in infectious diseases, 2016, Volume: 29, Issue:1 Topics: Anti-Infective Agents, Urinary; Cephalosporins; Diabetes Complications; Fever; Humans; Immunocompromised Host; Levofloxacin; Penicillanic Acid; Pyelonephritis; Randomized Controlled Trials as Topic; Risk Factors; Sepsis; Tazobactam; Treatment Outcome; Urinary Tract Infections	2016
[From cystitis to bacterial prostatitis: experience with levofloxacin]. Le infezioni in medicina, 2009, Volume: 17 Suppl 5 Topics: Anti-Bacterial Agents; Bacterial Infections; Cystitis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Multicenter Studies as Topic; Ofloxacin; Practice Guidelines as Topic; Prostatitis; Pyelonephritis; Randomized Controlled Trials as Topic; Risk Factors; Urethritis; Urinary Tract Infections	2009
The expanding role of fluoroquinolones. The American journal of medicine, 2002, Jul-08, Volume: 113 Suppl 1A Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Quinolones; Urinary Tract Infections	2002
Renal parenchymal malacoplakia: a rare cause of ARF with a review of recent literature. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:6 Topics: Acute Kidney Injury; Aged; Biopsy, Needle; Cefuroxime; Diagnosis, Differential; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Inclusion Bodies; Kidney; Kidney Diseases; Levofloxacin; Malacoplakia; Nephritis, Interstitial; Ofloxacin; Urinary Tract Infections	2003
Levofloxacin in the treatment of urinary tract infections and prostatitis. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16 Suppl 2 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostatitis; Quinolones; Severity of Illness Index; Treatment Outcome; Urinary Tract Infections	2004
[Levofloxacin (Tavanic) and therapy of urogenital infections]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:6 Topics: Animals; Female; Humans; Levofloxacin; Male; Ofloxacin; Urinary Tract Infections	2004
[Levofloxacin and other antibacterial drugs]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; Dermatitis; Dosage Forms; Humans; Levofloxacin; Ofloxacin; Otitis Media; Respiratory Tract Infections; Sinusitis; Urinary Tract Infections	2006
Usefulness and problems of the urinary tract infection criteria for evaluating drug efficacy for complicated urinary tract infections. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Amdinocillin Pivoxil; Anti-Infective Agents, Urinary; Cephalosporins; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Outcome; Urinary Tract Infections	2007
Levofloxacin and sparfloxacin: new quinolone antibiotics. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:3 Topics: Absorption; Anti-Infective Agents; Bronchitis; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones; Sinusitis; Skin Diseases; Urinary Tract Infections	1998
Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs, 1998, Volume: 56, Issue:3 Topics: Animals; Anti-Infective Agents; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections; Urinary Tract Infections	1998
[Levofloxacin for prevalent infections in primary care medicine]. Enfermedades infecciosas y microbiologia clinica, 1999, Volume: 17 Suppl 1 Topics: Anti-Infective Agents; Bacterial Infections; Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Primary Health Care; Respiratory Tract Infections; Urinary Tract Infections	1999
A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections. Drug safety, 2001, Volume: 24, Issue:3 Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Drug-Related Side Effects and Adverse Reactions; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Assessment; Skin Diseases, Bacterial; Urinary Tract Infections	2001
[The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2001, Volume: 46, Issue:7 Topics: Acute Disease; Animals; Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Humans; Levofloxacin; Maxillary Sinusitis; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Urinary Tract Infections	2001
[Role of levofloxacin in the treatment of urinary tract infections]. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2001, Volume: 73, Issue:2 Topics: Anti-Infective Agents, Urinary; Female; Humans; Levofloxacin; Male; Ofloxacin; Prostatitis; Urinary Tract Infections	2001
[Use of levofloxacin in the antibiotic prophylaxis for diagnostic procedures in urology]. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2002, Volume: 74, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Bacteriuria; Biopsy; Comorbidity; Diagnostic Techniques, Urological; Disease Susceptibility; Drug Evaluation; Endoscopy; Equipment Contamination; Humans; Incidence; Levofloxacin; Lithotripsy; Male; Middle Aged; Ofloxacin; Premedication; Prospective Studies; Prostate; Risk Factors; Urinary Catheterization; Urinary Tract Infections	2002

Trials

39 trial(s) available for levofloxacin and Urinary Tract Infections

Article	Year
Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Pyelonephritis; Urinary Tract Infections	2009
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9 Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pyelonephritis; Urinary Tract Infections	2009
Comparison of the Effectiveness of Pre-urodynamic Single-dose Levofloxacin with Post-urodynamic Levofloxacin for Three Days Related to the Incidence of Urinary Tract Infection: A Randomized Control Trial. Urology journal, 2023, May-21, Volume: 20, Issue:3 Topics: Anti-Bacterial Agents; Humans; Incidence; Levofloxacin; Single-Blind Method; Urinary Tract Infections; Urodynamics	2023
Effects of Catheter Tracking Management on Urinary Tract Function and Infection Rates in Patients With Spinal Cord Injury. Alternative therapies in health and medicine, 2023, Volume: 29, Issue:3 Topics: Anti-Bacterial Agents; Catheters; Ciprofloxacin; Gentamicins; Humans; Levofloxacin; Piperacillin; Quality of Life; Spinal Cord Injuries; Urinary Tract; Urinary Tract Infections	2023
Levofloxacin Versus Ceftriaxone for the Treatment of Acute Pyelonephritis in Iranian Adults. Infectious disorders drug targets, 2021, Volume: 21, Issue:4 Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Humans; Iran; Levofloxacin; Pyelonephritis; Urinary Tract Infections	2021
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam. BMC infectious diseases, 2017, 05-02, Volume: 17, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections	2017
A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:4 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Pyelonephritis; Sisomicin; Urinary Tract Infections; Young Adult	2018
Comparison of levofloxacin-based prophylaxis regimens for transrectal prostate biopsy: a prospective randomized single-center study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; China; Enema; Humans; Image-Guided Biopsy; Incidence; Levofloxacin; Male; Middle Aged; Prospective Studies; Prostate; Risk Factors; Urinary Tract Infections	2019
Sanjin tablets for acute uncomplicated lower urinary tract infection (syndrome of dampness-heat in the lower jiao): protocol for randomized, double-blind, double-dummy, parallel control of positive drug, multicenter clinical trial. Trials, 2019, Jul-19, Volume: 20, Issue:1 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; China; Double-Blind Method; Drugs, Chinese Herbal; Female; Humans; Levofloxacin; Lower Urinary Tract Symptoms; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Tablets; Time Factors; Treatment Outcome; Urinary Tract Infections; Young Adult	2019
Efficacy of antibiotic prophylaxis in patients undergoing cystoscopy: a randomized clinical trial. World journal of urology, 2013, Volume: 31, Issue:6 Topics: Adult; Aged; Anti-Bacterial Agents; Cystoscopy; Dose-Response Relationship, Drug; Female; Humans; Incidence; Levofloxacin; Male; Middle Aged; Outpatients; Single-Blind Method; Treatment Outcome; Urinary Tract Infections	2013
Are prophylactic antibiotics necessary in patients with preoperative sterile urine undergoing ureterorenoscopic lithotripsy? BJU international, 2014, Volume: 113, Issue:2 Topics: Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Cefazolin; Ceftriaxone; Double-Blind Method; Female; Fever; Humans; Levofloxacin; Lithotripsy; Male; Middle Aged; Odds Ratio; Postoperative Complications; Practice Guidelines as Topic; Preoperative Care; Prospective Studies; Pyuria; Treatment Outcome; Ureteroscopy; Urinary Tract Infections	2014
Quinolone prophylaxis in transrectal ultrasound guided prostate biopsy: an eight-year single center experience. TheScientificWorldJournal, 2013, Volume: 2013 Topics: Antibiotic Prophylaxis; Biopsy; Cefazolin; Humans; Levofloxacin; Male; Pipemidic Acid; Prostate; Retrospective Studies; Taiwan; Ultrasound, High-Intensity Focused, Transrectal; Urinary Tract Infections	2013
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Lancet (London, England), 2015, May-16, Volume: 385, Issue:9981 Topics: Adult; Aged; Anti-Infective Agents, Urinary; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult	2015
Effectiveness and tolerability of short course co-trimoxazole, norfloxacin and levofloxacin in bacteriological cure of uncomplicated urinary tract infection in outpatient setting. An open label, parallel group, randomized controlled trial. Le infezioni in medicina, 2015, Volume: 23, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; India; Levofloxacin; Male; Middle Aged; Norfloxacin; Outpatients; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2015
The Effectiveness of Prophylactic Antibiotics with Oral Levofloxacin against Post-Shock Wave Lithotripsy Infectious Complications: A Randomized Controlled Trial. Surgical infections, 2016, Volume: 17, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Incidence; Levofloxacin; Lithotripsy; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections; Young Adult	2016
A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle Biopsy. Urology journal, 2016, Mar-05, Volume: 13, Issue:1 Topics: Aged; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endosonography; Follow-Up Studies; Humans; Image-Guided Biopsy; Injections, Intravenous; Levofloxacin; Male; Prospective Studies; Prostate; Rectum; Single-Blind Method; Treatment Outcome; Urinary Tract Infections	2016
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Double-Blind Method; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult	2016
The Effectiveness of a Three Day Course Antibiotic Post-urodynamic Study in Preventing Lower Urinary Tract Infection. Acta medica Indonesiana, 2016, Volume: 48, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Incidence; Indonesia; Levofloxacin; Male; Middle Aged; Risk Factors; Urinary Tract Infections; Urine; Urodynamics	2016
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials. The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:1 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Metronidazole; Middle Aged; Penicillanic Acid; Tazobactam; Thienamycins; Treatment Outcome; Urinary Tract Infections; Young Adult	2017
Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections. BMC infectious diseases, 2016, 11-25, Volume: 16, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Injections, Intravenous; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Recurrence; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult	2016
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-i International urology and nephrology, 2017, Volume: 49, Issue:3 Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Aged; Anti-Infective Agents, Urinary; Female; Humans; Intention to Treat Analysis; Levofloxacin; Male; Middle Aged; Pyelonephritis; Treatment Outcome; Urinary Tract Infections	2017
Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:5 Topics: Administration, Oral; Adolescent; Aged; Anti-Bacterial Agents; China; Dizziness; Drug Administration Schedule; Female; Haemophilus influenzae; Humans; Levofloxacin; Male; Middle Aged; Nausea; Ofloxacin; Prospective Studies; Respiratory Tract Infections; Sleep Initiation and Maintenance Disorders; Streptococcus pneumoniae; Treatment Outcome; Urinary Tract Infections; Withholding Treatment	2009
Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritis. Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:6 Topics: Aged; Anti-Infective Agents, Urinary; Carbapenems; Doripenem; Double-Blind Method; Female; Genotype; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Urinary Tract Infections	2010
Antibiotic prophylaxis in catheter-associated urinary infections. The new microbiologica, 2012, Volume: 35, Issue:2 Topics: Antibiotic Prophylaxis; Female; Humans; Levofloxacin; Male; Ofloxacin; Urinary Catheterization; Urinary Tract Infections	2012
Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial. Chemotherapy, 2012, Volume: 58, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dioxolanes; Disk Diffusion Antimicrobial Tests; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Piperazines; Respiratory Tract Infections; Treatment Outcome; Urinary Tract Infections; Young Adult	2012
Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. The Journal of urology, 2002, Volume: 168, Issue:3 Topics: Administration, Oral; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Biopsy, Needle; Humans; Levofloxacin; Male; Ofloxacin; Prospective Studies; Prostate; Prostatic Neoplasms; Risk Factors; Ultrasonography, Interventional; Urinary Tract Infections	2002
[Faropenem 300 mg 3 times daily versus levofloxacin 100 mg 3 times daily in the treatment of urinary tract infections in patients with neurogenic bladder and/or benign prostatic hypertrophy]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2002, Volume: 76, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Drug Administration Schedule; Female; Humans; Lactams; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatic Hyperplasia; Urinary Bladder, Neurogenic; Urinary Tract Infections	2002
[Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections]. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2003, Volume: 75, Issue:1 Topics: Anti-Infective Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Follow-Up Studies; Humans; Levofloxacin; Ofloxacin; Pseudomonas Infections; Recurrence; Safety; Staphylococcal Infections; Streptococcal Infections; Superinfection; Treatment Outcome; Urinary Tract; Urinary Tract Infections	2003
Perioperative antibiotic prophylaxis in ureteroscopic stone removal. European urology, 2003, Volume: 44, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Antibiotic Prophylaxis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Perioperative Care; Probability; Prospective Studies; Reference Values; Risk Assessment; Treatment Outcome; Ureteral Calculi; Ureteroscopy; Urinary Tract Infections	2003
Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. European urology, 2005, Volume: 47, Issue:4 Topics: Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Drug Therapy, Combination; Humans; Levofloxacin; Male; Ofloxacin; Prospective Studies; Prostatectomy; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections	2005
A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Placebos; Pyuria; Single-Blind Method; Treatment Outcome; Urinary Catheterization; Urinary Tract Infections	2006
Early discharge of hospitalised patients with community-acquired urosepsis when treated with levofloxacin in sequential therapy. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2006, Volume: 78, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Community-Acquired Infections; Drug Administration Schedule; Female; Hospitalization; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Ofloxacin; Patient Discharge; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Urinary Tract Infections	2006
Usefulness and problems of the urinary tract infection criteria for evaluating drug efficacy for complicated urinary tract infections. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Amdinocillin Pivoxil; Anti-Infective Agents, Urinary; Cephalosporins; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Outcome; Urinary Tract Infections	2007
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Clinical therapeutics, 2007, Volume: 29, Issue:10 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections	2007
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology, 2008, Volume: 71, Issue:1 Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Urinary Catheterization; Urinary Tract Infections	2008
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA, 1998, Jan-14, Volume: 279, Issue:2 Topics: Adult; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Bayes Theorem; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections	1998
A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection. Urology, 1998, Volume: 51, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Quinolones; Urinary Tract Infections	1998
Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Annals of internal medicine, 2001, Jul-03, Volume: 135, Issue:1 Topics: Adult; Algorithms; Anti-Infective Agents, Urinary; Feasibility Studies; Female; Follow-Up Studies; Humans; Levofloxacin; Middle Aged; Ofloxacin; Patient Compliance; Patient Satisfaction; Prospective Studies; Reagent Kits, Diagnostic; Recurrence; Self Administration; Self Care; Urinary Tract Infections	2001
Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 1999, Volume: 32, Issue:1 Topics: Adult; Aged; Anti-Infective Agents; Bacteria; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Urinary Tract Infections	1999

Other Studies

91 other study(ies) available for levofloxacin and Urinary Tract Infections

Article	Year
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium	2010
Levofloxacin-induced symmetric drug-related intertriginous and flexural exanthema. Contact dermatitis, 2022, Volume: 86, Issue:1 Topics: Anti-Infective Agents, Urinary; Drug Eruptions; Exanthema; Female; Humans; Levofloxacin; Lymphocyte Activation; Middle Aged; Urinary Tract Infections	2022
Comparison between antimicrobial stewardship program and intervention by infection control team for managing antibiotic use in neurogenic bladder-related urinary tract infection patients: A retrospective chart audit. American journal of infection control, 2022, Volume: 50, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Stewardship; Cephalosporins; Escherichia coli; Humans; Infection Control; Klebsiella pneumoniae; Levofloxacin; Prospective Studies; Retrospective Studies; Urinary Bladder, Neurogenic; Urinary Tract Infections	2022
Evaluating outcomes associated with revised fluoroquinolone breakpoints for Enterobacterales urinary tract infections: A retrospective cohort study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022, Volume: 41, Issue:5 Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract Infections	2022
Management of antibacterial therapy of infectious and inflammatory diseases of the urinary tract in children and regional peculiarities during the COVID-19 pandemic. Journal of medicine and life, 2022, Volume: 15, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; COVID-19 Drug Treatment; Doxycycline; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Pandemics; Urinary Tract; Urinary Tract Infections	2022
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:9 Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2022
Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments. The American journal of emergency medicine, 2022, Volume: 61 Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cefuroxime; Cephalexin; Ciprofloxacin; Emergency Service, Hospital; Fluoroquinolones; Humans; Levofloxacin; Mexico; Nitrofurantoin; Retrospective Studies; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections	2022
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Anti-Bacterial Agents; Doripenem; Humans; Imipenem; Levofloxacin; Urinary Tract Infections	2023
Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study. BMJ (Clinical research ed.), 2022, 10-04, Volume: 379 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Emergency Service, Hospital; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Hospitals; Humans; Levofloxacin; Moxifloxacin; Norfloxacin; Retrospective Studies; Suicidal Ideation; Suicide; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2022
A preventable, life-altering case of fluoroquinolone-associated tendonitis. JAAPA : official journal of the American Academy of Physician Assistants, 2022, Nov-01, Volume: 35, Issue:11 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Tendinopathy; Urinary Tract Infections	2022
Genotypic Detection of Archives of Razi Institute, 2022, Volume: 77, Issue:2 Topics: Agar; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Ciprofloxacin; Citrobacter koseri; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections	2022
Sitafloxacin pharmacokinetics/pharmacodynamics against multidrug-resistant bacteria in a dynamic urinary tract infection in vitro model. The Journal of antimicrobial chemotherapy, 2022, 12-23, Volume: 78, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Escherichia coli; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Vancomycin	2022
Antibiotic Sensitivity of International journal of clinical practice, 2022, Volume: 2022 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; Sulbactam; Sulfamethoxazole; Urinary Calculi; Urinary Tract Infections	2022
Microbiological Spectrum and Antibiogram of Urinary Tract Infection in a Tertiary Care Center from the Kingdom of Bahrain. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2022, Volume: 33, Issue:Supplement Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bahrain; beta-Lactamases; Carbapenems; Ciprofloxacin; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Levofloxacin; Male; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2022
Antibacterial and Antibiofilm Activities of Ceragenins Alone and in Combination with Levofloxacin Against Multidrug Resistant Myroides spp. Clinical Isolates from Patients with Urinary Tract Infections. Current microbiology, 2023, May-16, Volume: 80, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Flavobacteriaceae; Humans; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections	2023
Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Antimicrobial agents and chemotherapy, 2019, 12-20, Volume: 64, Issue:1 Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Fosfomycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Rifampin; Urinary Tract Infections	2019
The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Humans; Japan; Klebsiella pneumoniae; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Proteus mirabilis; Pseudomonas aeruginosa; Urinary Tract Infections; Vancomycin; Young Adult	2020
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study. BMC urology, 2020, Apr-06, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2020
In vitro activity of omadacycline and levofloxacin against Escherichia coli, Klebsiella pneumoniae and Staphylococcus saprophyticus in human urine supplemented with calcium and magnesium. The Journal of antimicrobial chemotherapy, 2020, 08-01, Volume: 75, Issue:8 Topics: Anti-Bacterial Agents; Calcium; Escherichia coli; Humans; Klebsiella pneumoniae; Levofloxacin; Magnesium; Microbial Sensitivity Tests; Staphylococcus saprophyticus; Tetracyclines; Urinary Tract Infections	2020
Comparison of UTI antibiograms stratified by ED patient disposition. The American journal of emergency medicine, 2017, Volume: 35, Issue:9 Topics: Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Emergency Service, Hospital; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections	2017
Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Disease Models, Animal; Ertapenem; Escherichia coli Infections; Female; Humans; Levofloxacin; Mice, Inbred ICR; Microbial Sensitivity Tests; Urinary Tract Infections; Uropathogenic Escherichia coli	2017
Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections. International journal of clinical pharmacy, 2018, Volume: 40, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cohort Studies; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections	2018
Respiratory microsporidiosis caused by Enterocytozoon bieneusi in an HIV-negative hematopoietic stem cell transplant recipient. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 77 Topics: Albendazole; Bronchoalveolar Lavage; Enterocytozoon; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Immunocompromised Host; Levofloxacin; Microsporidiosis; Risk Factors; Urinary Tract Infections; Young Adult	2018
Anaphylactic shock secondary to oral ofloxacin administration with cross-reactivity to levofloxacin and ciprofloxacin. Therapie, 2018, Volume: 73, Issue:6 Topics: Administration, Oral; Adolescent; Anaphylaxis; Ciprofloxacin; Cross Reactions; Drug Hypersensitivity; Escherichia coli Infections; Female; Humans; Levofloxacin; Ofloxacin; Skin Tests; Urinary Tract Infections	2018
Comparative The Pan African medical journal, 2018, Volume: 30 Topics: Adult; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Fluoroquinolones; Ghana; Humans; In Vitro Techniques; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Pilot Projects; Urinary Tract Infections; Young Adult	2018
Comparison of intravenous and oral definitive antibiotic regimens in hospitalised patients with Gram-negative bacteraemia from a urinary tract infection. Journal of global antimicrobial resistance, 2019, Volume: 18 Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Female; Gram-Negative Bacteria; Humans; Kaplan-Meier Estimate; Length of Stay; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Failure; Urinary Tract Infections	2019
[THE RISK FACTORS AND CHEMOPREVENTION OF FEBRILE URINARY TRACT INFECTION AFTER TRANSURETHRAL URETEROLITHOTRIPSY]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2018, Volume: 109, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Child; Female; Fever; Humans; Levofloxacin; Lithotripsy, Laser; Male; Middle Aged; Operative Time; Risk Factors; Ureter; Ureteral Calculi; Urethra; Urinary Tract Infections; Young Adult	2018
Postoperative bacteriuria, pyuria and urinary tract infection in patients with an orthotopic sigmoid colon neobladder replacement. The Journal of antibiotics, 2014, Volume: 67, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacteriuria; Cefepime; Cephalosporins; Colon, Sigmoid; Cystectomy; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Postoperative Complications; Prevalence; Pyuria; Staphylococcus aureus; Sulfamethoxazole; Tazobactam; Thienamycins; Trimethoprim; Urinary Diversion; Urinary Tract Infections	2014
Resistance of Escherichia coli urinary isolates in ED-treated patients from a community hospital. The American journal of emergency medicine, 2014, Volume: 32, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Emergency Service, Hospital; Escherichia coli Infections; Female; Hospitals, Community; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2014
Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coli. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4 Topics: Anti-Bacterial Agents; Biofilms; Colistin; Colony Count, Microbial; Escherichia coli Infections; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Tetracyclines; Thienamycins; Urinary Tract Infections; Uropathogenic Escherichia coli	2015
Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Costs and Cost Analysis; Ertapenem; Escherichia coli; Female; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult	2016
A new ASPECT for complicated urinary tract infections. Lancet (London, England), 2015, May-16, Volume: 385, Issue:9981 Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections	2015
Infection: Ceftolozane-tazobactam gives a new ASPECT to the fight against antimicrobial resistance. Nature reviews. Urology, 2015, Volume: 12, Issue:6 Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections	2015
Characterization and antibiotic susceptibility of Streptococcus agalactiae isolates causing urinary tract infections. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2015, Volume: 34 Topics: Anti-Bacterial Agents; Cefaclor; Ceftriaxone; Cefuroxime; Disk Diffusion Antimicrobial Tests; DNA Gyrase; Drug Resistance, Bacterial; Erythromycin; Humans; Levofloxacin; Penicillins; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Urinary Tract Infections	2015
Trends of fluoroquinolone-resistant Escherichia coli amongst urinary isolates in children: a 10 year surveillance study. Journal of medical microbiology, 2015, Volume: 64, Issue:7 Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Microbial Sensitivity Tests; Urinary Tract Infections	2015
Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram. The Journal of emergency medicine, 2015, Volume: 49, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Emergency Service, Hospital; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2015
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection. Lancet (London, England), 2015, Sep-26, Volume: 386, Issue:10000 Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections	2015
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection. Lancet (London, England), 2015, Sep-26, Volume: 386, Issue:10000 Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections	2015
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection. Lancet (London, England), 2015, Sep-26, Volume: 386, Issue:10000 Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections	2015
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection - Authors' reply. Lancet (London, England), 2015, Sep-26, Volume: 386, Issue:10000 Topics: Anti-Infective Agents, Urinary; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Penicillanic Acid; Urinary Tract Infections	2015
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST]. Mikrobiyoloji bulteni, 2015, Volume: 49, Issue:4 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli	2015
Changes in minimum inhibitory concentration of levofloxacin for Escherichia coli strains isolated from urine samples in mainland China, 2004 to 2014. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:3 Topics: Anti-Bacterial Agents; China; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Urine	2017
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. Journal of medical microbiology, 2017, Volume: 66, Issue:1 Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections	2017
5-Day versus 10-Day Course of Fluoroquinolones in Outpatient Males with a Urinary Tract Infection (UTI). Journal of the American Board of Family Medicine : JABFM, 2016, 11-12, Volume: 29, Issue:6 Topics: Administration, Intravenous; Administration, Oral; Adult; Ambulatory Care; Ciprofloxacin; Escherichia coli; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Sex Factors; Time Factors; Urinary Tract Infections	2016
Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Urine	2017
Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Urinary Tract Infections	2017
Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. The American journal of medicine, 2008, Volume: 121, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Levofloxacin; Middle Aged; Ofloxacin; Urinary Tract Infections	2008
[Prevention of peri-operative infection with levofloxacin in female patients undergoing surgery for stress urinary incontinence]. Zhonghua yi xue za zhi, 2008, Jun-03, Volume: 88, Issue:21 Topics: Administration, Oral; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Levofloxacin; Middle Aged; Ofloxacin; Tablets; Treatment Outcome; Urinary Incontinence, Stress; Urinary Tract Infections	2008
Urinary Mycobacterium szulgai infection in an immunocompetent patient. Southern medical journal, 2009, Volume: 102, Issue:9 Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Immunocompetence; Isoniazid; Levofloxacin; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Rifampin; Urinary Tract Infections	2009
[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007]. The Japanese journal of antibiotics, 2009, Volume: 62, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gastrointestinal Diseases; Humans; Japan; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Time Factors; Urinary Tract Infections	2009
Microbiological outcome of complicated urinary tract infections treated with levofloxacin: a pharmacokinetic/pharmacodynamic analysis. International journal of antimicrobial agents, 2010, Volume: 35, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Computer Simulation; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Serum; Treatment Outcome; Urinary Tract Infections; Urine	2010
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations. BMC microbiology, 2010, Apr-21, Volume: 10 Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dioxolanes; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Klebsiella; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Piperazines; Respiratory Tract Infections; Selection, Genetic; Urinary Tract Infections	2010
Catheter-associated urinary tract infection IDSA guidelines: why the levofloxacin? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Aug-15, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheter-Related Infections; Humans; Levofloxacin; Ofloxacin; Practice Guidelines as Topic; Treatment Outcome; Urinary Tract Infections	2010
Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections. Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Ofloxacin; Risk Factors; Sequence Analysis, DNA; Urinary Tract Infections	2011
High rates of quinolone resistance among urinary tract infections in the ED. The American journal of emergency medicine, 2012, Volume: 30, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Quinolones; Retrospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2012
Evaluation by Monte Carlo simulation of levofloxacin dosing for complicated urinary tract infections caused by Escherichia coli or Pseudomonas aeruginosa. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Area Under Curve; Computer Simulation; Databases, Factual; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Models, Statistical; Monte Carlo Method; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections	2011
Mechanisms of and risk factors for fluoroquinolone resistance in clinical Enterococcus faecalis isolates from patients with urinary tract infections. Journal of clinical microbiology, 2011, Volume: 49, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Ofloxacin; Risk Factors; Urinary Tract Infections; Young Adult	2011
Relationship between urinary tract infection categorization and pathogens' antimicrobial susceptibilities. Urologia internationalis, 2012, Volume: 88, Issue:2 Topics: Anti-Infective Agents; Catheter-Related Infections; Ceftazidime; Enterococcus faecalis; Escherichia coli; Humans; Inpatients; Japan; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Outpatients; Pseudomonas aeruginosa; Time Factors; Urinary Catheterization; Urinary Tract Infections; Urology Department, Hospital	2012
Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012, Volume: 95 Suppl 2 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Respiratory Tract Infections; Thailand; Urinary Tract Infections	2012
Acute renal failure caused by severe coagulopathy induced by the interaction between warfarin potassium and levofloxacin: a case report. Journal of anesthesia, 2012, Volume: 26, Issue:6 Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anticoagulants; Blood Coagulation Disorders; Cardiomyopathy, Dilated; Drug Interactions; Hematuria; Humans; International Normalized Ratio; Levofloxacin; Male; Ofloxacin; Shock; Urinary Tract Infections; Warfarin	2012
Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2014, Volume: 47, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Risk Factors; Taiwan; Urinary Tract Infections; Young Adult	2014
Four consecutive cases of Achilles tendon disorders associated with levofloxacin treatment in hemodialysis patients. Clinical and experimental nephrology, 2012, Volume: 16, Issue:6 Topics: Achilles Tendon; Administration, Oral; Aged; Anti-Infective Agents, Urinary; Dose-Response Relationship, Drug; Humans; Kidney Failure, Chronic; Levofloxacin; Male; Middle Aged; Ofloxacin; Renal Dialysis; Retrospective Studies; Tendinopathy; Treatment Outcome; Urinary Tract Infections	2012
Levofloxacin-induced granulomatous interstitial nephritis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2003, Volume: 41, Issue:2 Topics: Female; Granuloma; Humans; Levofloxacin; Middle Aged; Nephritis, Interstitial; Ofloxacin; Urinary Tract Infections	2003
[Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002]. The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cefdinir; Cephalosporins; Ciprofloxacin; Dosage Forms; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Macrolides; Ofloxacin; Otorhinolaryngologic Diseases; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Urinary Tract Infections	2002
[Comparative in vitro bacteriostatic and bactericidal activity of levofloxacin and ciprofloxacin against urinary tract pathogens determined by MIC, MBC, Time-Kill curves and bactericidal index analysis]. Le infezioni in medicina, 2002, Volume: 10, Issue:2 Topics: Anti-Infective Agents; Ciprofloxacin; Gram-Negative Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Urinary Tract Infections	2002
Urinary tract infection caused by Aerococcus viridans, a case report. Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:11 Topics: Aged; Aged, 80 and over; Bacteremia; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Ofloxacin; Streptococcaceae; Urinary Tract Infections	2004
[Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community]. Pathologie-biologie, 2005, Volume: 53, Issue:2 Topics: Anti-Infective Agents, Urinary; Bacterial Infections; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Urinary Tract Infections	2005
[Uroinfections and the possibilities of therapy with levofloxacin]. Khirurgiia, 2004, Volume: 60, Issue:4-5 Topics: Anti-Infective Agents, Urinary; Drug Administration Schedule; Genital Diseases, Male; Humans; Levofloxacin; Male; Ofloxacin; Treatment Outcome; Urinary Tract Infections; Urine	2004
[Results of the study on antibiotic resistance emergence among pathogens of community-acquired urinary tract infections in Moscow. Phase I]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2005, Volume: 50, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacterial Infections; Cephalosporins; Community-Acquired Infections; Drug Resistance; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Moscow; Ofloxacin; Urinary Tract Infections	2005
Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Urinary Tract Infections	2005
Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event? Southern medical journal, 2006, Volume: 99, Issue:1 Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Levofloxacin; Long QT Syndrome; Male; Ofloxacin; Prognosis; Prospective Studies; Prostatitis; Respiratory Tract Infections; Severity of Illness Index; Urinary Tract Infections	2006
Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:1 Topics: Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Drug Tolerance; Female; Humans; Levofloxacin; Liver Diseases; Male; Middle Aged; Ofloxacin; Peritonitis; Pneumonia; Prospective Studies; Urinary Tract Infections	2006
A Rare but serious side effect of Levofloxacin: hypoglycemia in a geriatric patient. Diabetes care, 2006, Volume: 29, Issue:7 Topics: Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemia; Levofloxacin; Middle Aged; Ofloxacin; Pneumonia; Urinary Tract Infections	2006
Continuous versus intermittent levofloxacin treatment in complicated urinary tract infections caused by urinary obstruction temporarily relieved by foreign body insertion. International journal of antimicrobial agents, 2006, Volume: 28 Suppl 1 Topics: Anti-Infective Agents, Urinary; Biofilms; Drug Administration Schedule; Female; Foreign Bodies; Humans; Levofloxacin; Male; Ofloxacin; Stents; Urethral Obstruction; Urinary Tract Infections	2006
Prevalence and natural history of colonization with fluoroquinolone-resistant gram-negative bacilli in community-dwelling people with spinal cord dysfunction. Archives of physical medicine and rehabilitation, 2006, Volume: 87, Issue:10 Topics: Anti-Bacterial Agents; Carrier State; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Gram-Negative Aerobic Bacteria; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Perineum; Prevalence; Prospective Studies; Spinal Cord Diseases; Urinary Catheterization; Urinary Incontinence; Urinary Tract Infections	2006
Levofloxacin-induced interstitial nephritis and vasculitis in an elderly woman. The Israel Medical Association journal : IMAJ, 2006, Volume: 8, Issue:10 Topics: Acute Kidney Injury; Aged, 80 and over; Anti-Bacterial Agents; Fatal Outcome; Female; Humans; Levofloxacin; Myelodysplastic Syndromes; Nephritis, Interstitial; Ofloxacin; Purpura; Urinary Tract Infections; Vasculitis	2006
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance. International journal of antimicrobial agents, 2007, Volume: 29, Issue:6 Topics: Anti-Infective Agents, Urinary; Bacterial Adhesion; Ciprofloxacin; Dioxolanes; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hemolysin Proteins; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Ultraviolet Rays; Urinary Tract Infections	2007
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens]. Le infezioni in medicina, 2006, Volume: 14, Issue:1 Topics: Anti-Bacterial Agents; Ciprofloxacin; Dioxolanes; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Quinolones; Staphylococcus aureus; Urinary Tract Infections	2006
[Drug-resistant bacteria isolated from pharyngeal swab cultures and urine in acutely or chronically febrile elderly nursing home inmates]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2007, Volume: 44, Issue:3 Topics: Acute Disease; Aged; Chronic Disease; Drug Resistance, Bacterial; Escherichia coli; Fever; Fluoroquinolones; Humans; Levofloxacin; Nursing Homes; Ofloxacin; Penicillin Resistance; Pharynx; Staphylococcus aureus; Streptococcus pneumoniae; Urinary Tract Infections; Urine	2007
Multidrug-induced erythema multiforme. Journal of investigational allergology & clinical immunology, 2007, Volume: 17, Issue:3 Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Hypersensitivity; Erythema Multiforme; Female; Humans; Levofloxacin; Methenamine; Ofloxacin; Piroxicam; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2007
Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2008, Volume: 14, Issue:1 Topics: Aged; Anti-Bacterial Agents; Biopsy, Needle; Blood; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostate; Prostatitis; Ultrasound, High-Intensity Focused, Transrectal; Urinary Tract Infections; Urine	2008
[Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group]. The Japanese journal of antibiotics, 2000, Volume: 53, Issue:6 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Respiratory Tract Infections; Urinary Tract Infections	2000
[Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)]. Revue medicale de Liege, 2000, Volume: 55, Issue:11 Topics: Acute Disease; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Bronchitis; Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Sinusitis; Urinary Tract Infections	2000
Levofloxacin induced polymorphic ventricular tachycardia with normal QT interval. Pacing and clinical electrophysiology : PACE, 2001, Volume: 24, Issue:5 Topics: Anti-Infective Agents, Urinary; Electrocardiography; Female; Humans; Levofloxacin; Middle Aged; Ofloxacin; Syncope; Tachycardia, Ventricular; Urinary Tract Infections	2001
Activity of levofloxacin and ciprofloxacin against urinary pathogens. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:1 Topics: Anti-Infective Agents; Bacterial Adhesion; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Urinary Tract Infections	2001
Acute fatal hepatitis related to levofloxacin. Journal of hepatology, 2001, Volume: 35, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Chemical and Drug Induced Liver Injury; Fatal Outcome; Humans; Levofloxacin; Liver Failure, Acute; Male; Ofloxacin; Urinary Tract Infections	2001
Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different! Diagnostic microbiology and infectious disease, 2001, Volume: 41, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Gatifloxacin; Humans; Lactams; Latin America; Levofloxacin; Microbial Sensitivity Tests; North America; Ofloxacin; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections; Regional Medical Programs; Urinary Tract Infections	2001
[Efficacy of a single-day administration of levofloxacin for the prevention of urinary tract infections after urogenital examinations and treatments for outpatients]. Hinyokika kiyo. Acta urologica Japonica, 2001, Volume: 47, Issue:11 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents, Urinary; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Outpatients; Urinary Tract Infections	2001
Effect of subminimal inhibitory concentrations of three fluoroquinolones on adherence of uropathogenic strains of Escherichia coli. International journal of antimicrobial agents, 2002, Volume: 19, Issue:1 Topics: Anti-Infective Agents; Bacterial Adhesion; Cell Line; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Female; Hemagglutination; Humans; Inhibitory Concentration 50; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Urinary Tract Infections	2002
The dipstick test in the diagnosis of UTI and the effect of pretreatment catheter exchange in catheter-associated UTI. Infection, 1992, Volume: 20 Suppl 3 Topics: Bacteriuria; Esterases; Evaluation Studies as Topic; Humans; Japan; Leukocyte Count; Levofloxacin; Nitrates; Ofloxacin; Pyuria; Reagent Kits, Diagnostic; Urinary Catheterization; Urinary Tract Infections; Urine	1992
[Clinical study of levofloxacin (DR-3355) on uro-genital infections--with special reference to usefulness for chronic prostatitis]. Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:6 Topics: Adult; Aged; Chronic Disease; Drug Administration Schedule; Epididymitis; Escherichia coli; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Staphylococcus; Urinary Tract Infections	1992